TCF3-ZNF384-rearranged B-ALL represents the most frequent fusion gene involving ZNF384 and is characterized by a poorer chemotherapeutic response and a higher frequency of relapse compared to the other ZNF384 rearrangements [58]. Here, ZNF384 is linked to precursor B-cell acute lymphoblastic leukemia.